Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction.

Drug and alcohol dependence | 2014

This study tests whether the genetic predictor (CHRNA5 nicotine receptor gene variants) and an environmental risk factor (partner smoking) interact in the prediction of smoking reduction.

Pubmed ID: 25073833 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG004438
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_12013/6
  • Agency: NIDA NIH HHS, United States
    Id: K08 DA030398
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UU_12013/1
  • Agency: NCI NIH HHS, United States
    Id: P50 CA84724
  • Agency: Wellcome Trust, United Kingdom
    Id: 102215
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000448
  • Agency: NIDA NIH HHS, United States
    Id: K02 DA021237
  • Agency: Medical Research Council, United Kingdom
    Id: G9815508
  • Agency: NCRR NIH HHS, United States
    Id: KL2 RR024994
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA031288
  • Agency: NCI NIH HHS, United States
    Id: K05 CA139871
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG004446
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL109031
  • Agency: NIAAA NIH HHS, United States
    Id: R01 AA017444
  • Agency: NCI NIH HHS, United States
    Id: P01 CA089392
  • Agency: NIDA NIH HHS, United States
    Id: P50 DA19706
  • Agency: NCI NIH HHS, United States
    Id: P01 CA180945
  • Agency: NIDA NIH HHS, United States
    Id: P50 DA019706
  • Agency: Medical Research Council, United Kingdom
    Id: MC_PC_15018
  • Agency: NHGRI NIH HHS, United States
    Id: HHSN268200782096C
  • Agency: NCI NIH HHS, United States
    Id: P50 CA084724
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG004422
  • Agency: Wellcome Trust, United Kingdom
    Id: 092731

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


1000 Genomes: A Deep Catalog of Human Genetic Variation (tool)

RRID:SCR_006828

International collaboration producing an extensive public catalog of human genetic variation, including SNPs and structural variants, and their haplotype contexts, in an effort to provide a foundation for investigating the relationship between genotype and phenotype. The genomes of about 2500 unidentified people from about 25 populations around the world were sequenced using next-generation sequencing technologies. Redundant sequencing on various platforms and by different groups of scientists of the same samples can be compared. The results of the study are freely and publicly accessible to researchers worldwide. The consortium identified the following populations whose DNA will be sequenced: Yoruba in Ibadan, Nigeria; Japanese in Tokyo; Chinese in Beijing; Utah residents with ancestry from northern and western Europe; Luhya in Webuye, Kenya; Maasai in Kinyawa, Kenya; Toscani in Italy; Gujarati Indians in Houston; Chinese in metropolitan Denver; people of Mexican ancestry in Los Angeles; and people of African ancestry in the southwestern United States. The goal Project is to find most genetic variants that have frequencies of at least 1% in the populations studied. Sequencing is still too expensive to deeply sequence the many samples being studied for this project. However, any particular region of the genome generally contains a limited number of haplotypes. Data can be combined across many samples to allow efficient detection of most of the variants in a region. The Project currently plans to sequence each sample to about 4X coverage; at this depth sequencing cannot provide the complete genotype of each sample, but should allow the detection of most variants with frequencies as low as 1%. Combining the data from 2500 samples should allow highly accurate estimation (imputation) of the variants and genotypes for each sample that were not seen directly by the light sequencing. All samples from the 1000 genomes are available as lymphoblastoid cell lines (LCLs) and LCL derived DNA from the Coriell Cell Repository as part of the NHGRI Catalog. The sequence and alignment data generated by the 1000genomes project is made available as quickly as possible via their mirrored ftp sites. ftp://ftp.1000genomes.ebi.ac.uk ftp://ftp-trace.ncbi.nlm.nih.gov/1000genomes

View all literature mentions

Illumina (tool)

RRID:SCR_010233

American company incorporated that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. Provides a line of products and services that serve the sequencing, genotyping and gene expression and proteomics markets. Its headquarters are located in San Diego, California.

View all literature mentions